The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

GRAEF Rechtsanwälte

Work +49 40 80 6000 90
Fax +49 40 80 6000 91 0
Berlin, Hamburg
GRAEF Rechtsanwälte, Dr Christian Rauda, Hamburg, GERMANY


Dr Christian Rauda

Work +49 40 80 6000 9 0
GRAEF Rechtsanwälte

Work Department

Media & Entertainment Law Group


DR. CHRISTIAN RAUDA ist Fachanwalt für gewerblichen Rechtsschutz, Fachanwalt für Urheber- und Medienrecht und Justiziar des Deutschen Internetverbandes. Von 2005 bis 2008 war er als Anwalt in eigener Kanzlei und einer überregionalen Medien-rechtskanzlei tätig. Seit 2008 ist er Partner der Medienrechtskanzlei GRAEF Rechts-anwälte. Er ist Autor zahlreicher juristischer Fachbücher und Dozent an der Johannes-Gutenberg Universität Mainz und der Hamburg Media School. Schwerpunkte: Urheber-, Marken- und Wettbewerbsrecht, Games.


1999 – 2003 Freier Mitarbeiter im Marken- und Urheberrecht, Rechtsanwaltssozietät Mayer, Brown, Rowe & Maw, Frankfurt/Main 1999 – 2004 Auslandserfahrung in auf Marken-, Urheber- und Wettbewerbsrecht spezialisierten Kanzleien in New York, Genf und Chicago 2004 – 2006 Rechtsanwalt in eigener marken- und medienrechtlich ausgerichteten Kanzlei 2007 – 2008 Rechtsanwalt in der Medienrechtskanzlei Unverzagt von Have 2008 Partner der Medienrechtskanzlei GRAEF Rechtsanwälte


Deutsch Englisch Französisch


seit 2008 Justiziar des Deutschen Internet Verbandes seit 2008 Experte des Fachmagazins für Marketing und Vertrieb „acquisa“ Lehrbeauftragter der Johannes Gutenberg-Universität Mainz Dozent der Hamburg Media School Board-Mitglied des Institute for Business Communication Research, Oxford


1996 – 1998 Studium der Rechtswissenschaften an der Johannes Gutenberg-Universität Mainz 1998 – 1999 Auslandsjahr an der Université de Genève und der Université de Lausanne (Studienschwerpunkt: schweizerisches und europäisches Recht des geistigen Eigentums) 1999 – 2002 Studium der Rechtswissenschaften an der Johannes Gutenberg-Universität Mainz 2002 Erstes Juristisches Staatsexamen, Universität Mainz 2004 Zweites Juristisches Staatsexamen, Oberlandesgericht Koblenz 2004 – 2006 Promotion (Dr. iur.) Universität Mainz 2008 Fachanwalt für gewerblichen Rechtsschutz 2010 Fachanwalt für Urheber- und Medienrecht

Deutschland 2018: Medien


Within: Entertainment

Graef Rechtsanwälte wartet mit besonders tiefgreifender Erfahrung bei der medien- und urheberrechtlichen Betreuung von Produktionsfirmen, Filmstudios und Fernsehsendern auf, ist jedoch ebenso in den Bereichen eCommerce und Games aktiv. Ralph Graef beriet zuletzt beispielsweise Animationsfabrik umfänglich im Rahmen der Filmprojekte “Prinzessin Emmy” und “Zac & Zoe”, begleitete ARTE bei der Ausgründung des arte-Magazins mit Axel Springer und betreut zudem regelmäßig unter anderem BBC Worldwide, EPIC Films, studio rakete und DOCDAYS Productions bei filmrechtlichen Fragestellungen zu Co-Produktionen. Auf streitiger Ebene vertrat man außerdem ACCENTA Music & P.O.S. in einer Auseinandersetzung mit einer Verwertungsgesellschaft und im Games-Segment unterstützt der ‘sehr guteChristian Rauda beispielsweise Gentle Troll Entertainment zu medienrechtlichen Themen im Bereich Serious Games. Alexander Graf von Kalckreuth steht der Kanzlei seit 2017 nicht mehr als Of Counsel zur Verfügung.

[von unten nach oben]

Back to index

Co-Publishing weltweit

Rechtsentwicklungen und Neuigkeiten der führenden Anwälte in verschiedenen Jurisdiktionen. Für Beitrüge schicken Sie bitte eine Anfrage per Email an
  • China Drug Registration Regulation - Public consultation on amendment closes - March 2014

    In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.
  • The Hong Kong Competition Ordinance - September 2014

    The Hong Kong Competition Ordinance was enacted by the Legislative Council in June 2012. You can download our briefing here .
  • Mobile payments: Change in your pocket with new opportunities - October 2014

    The mobile payments industry is developing rapidly. Increasingly integrated within the global economy, the ability to make mobile payments brings traditional players in the payments industry (such as financial institutions operating as merchant acquirers) together with retailers, mobile network operators (MNO) and other technology suppliers.
  • Revised NDRC Measures for Approval and Filing of Outbound Investment Projects - April 2014

    The National Development and Reform Commission ( NDRC ) released a new set of Management Measures for Approval and Filing of Outbound Investment Projects ( 境外投资项目核准和备案管理办法) ( New Measures ) on 8 April 2014. The New Measures take effect on 8 May 2014 and will replace the Interim Management Measures for Approval of Outbound Investment Projects ( 境外投资项目核准暂行管理办法) ( Original Measures ) which have been in force since 9 October 2004.
  • Insurance Update - CIRC Issues Insurance M&A Measures: What are the impacts and applications?

    On 21 March 2014, CIRC issued the Administrative Measures on the Acquisition and Merger of Insurance Companies (the Insurance M&A Measures ) which will take effect from 1 June 2014. The Insurance M&A Measures apply to M&A activities whereby an insurance company is the target for a merger or acquisition. The target insurance company could be either a domestic or a foreign invested insurer. However, the Insurance M&A Measures will not apply to any equity investment by insurance companies in non-insurance companies in China or in overseas insurance companies.
  • China issues new rules to regulate medical devices - May 2014

    The Regulations on Supervision and Administration of Medical Devices (in Chinese《医疗器械监督管理条例》, State Council Order No. 650) (the Medical Device Regulations) were amended by China's State Council on 31 March 2014 and will come into effect on 1 June 2014. This is the first amendment in more than a decade since the Medical Device Regulations were first promulgated in 2000, even though the amendment was initiated eight years ago in 2006. The 2014 amendment unveils reforms on the regulatory regime for medical devices market in China from various aspects.
  • Hong Kong: The evolving role of independent non-executive directors - May 2014

     In a recent speech given by Mr. Carlson Tong, Chairman of the Securities and Futures Commission, Mr. Tong pointed out that companies can improve corporate governance by attaching higher importance to the role of their board of directors as an internal gatekeeper. Mr. Tong said that this can be done more easily by having effective independent non-executive directors (INEDs) on the board.
  • Walking a fine line in China:Distinguishing between legitimate commercial deals and commercial bribe

    China in the 21st century exemplifies an atmosphere of great opportunity and intense competition. Against this backdrop, it has become increasingly common for businesses to adopt a variety of practices in order to make their products and services competitive. Such practices may include paying middle-men to promote sales and giving incentives to buyers directly. However, whilst revenue spikes are undoubtedly welcome, businesses should bear in mind the potential backlash arising out of these commercial arrangements. The risk that such arrangements may not comply with anti-bribery and corruption laws and therefore cause business significant damage in the long term should not be underestimated.
  • Competition law developments in East Asia - May 2014

    Authorities in Hong Kong have taken further steps in their deliberate approach to enforcing the Competition Ordinance. A little over a year after it was appointed, the Competition Commission released a report in which it provides a brief introduction to the Ordinance as well as a roadmap leading to its full entry into force. The report also explains how the Commission will prioritise its enforcement activities, and identifies the guidelines, policies and compliance tools which it plans to release before the Ordinance is enforced. Currently only some of the institutional provisions of the Ordinance are effective, allowing the Commission and the Competition Tribunal to prepare for enforcement.
  • Rise of the private healthcare sector - July 2014

    As of 2013, China had 9,800 private hospitals, representing almost half of the total number of hospitals in the country 1 . However, private hospitals still severely lag behind their public peers due to low utilisation, talent shortages and incomplete social insurance coverage. As part of China's ongoing healthcare reform initiatives, the Chinese government has set a goal to increase the share of patients treated by private hospitals to 20% by the end of 2015 2 .